TrialAntimicrobial agents and chemotherapy2008

Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen.

Aurélie Barrail-Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.